A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

Heritage Medical Systems has backed a $25m series B round for the Caltech spinout, which is developing therapies for Parkinson’s and Autism spectrum disorder.

GV and Alexandria have taken part in a $191m round to launch Maze Therapeutics with scientific co-founders from multiple universities such as Harvard and Stanford.

University of St Thomas has teamed up with Gener8tor to launch two accelerators for students and startups affiliated with the university.

Sanger Institute-founded PetMedix is working on antibodies for dogs and cats based on an immune system discovery model that will adapt and extend earlier human health research.

Wisconsin Alumni Research Foundation has set up a pre-clinical drug discovery operation called Warf Therapeutics to help support biomedical projects.

EU-owned institutions including the EIF are pouring capital and assistance into an early-stage tech transfer vehicle for the Fraunhofer network of applied research institutes.

University of Virginia spectroscopy spinout BrightSpec has added series B capital from investors including the university's seed fund to an earlier $1.5m sum raised in 2015.

Alphabet's venturing unit has led a $22m series A extension for MIT spinout Lightmatter, which increased the round's total to $33m.

The UC Berkeley-founded MRI scanner technology spinout graduated from the SkyDeck accelerator in 2018 and has now announced its inaugural round of funding.